top of page

Aisling Capital's Dennis Purcell gives his take on the current state of biotech

Dennis Purcell talks about the biotech downturn, what areas of science interest him going forward, and memories of Hambrecht & Quist.



Join the BiotechTV mailing list

Thanks for subscribing!

bottom of page